Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: A mechanism for the attenuation of post-ischemic injury and epileptiform activity?

Neuropharmacology

Volumn 43, Issue 2, 2002, Pages 119-130

  Cozzi, Andrea ^a   Meli, Elena ^a   Carlà, Vincenzo ^a   Pellicciari, Roberto ^a   Moroni, Flavio ^a   Pellegrini Giampietro, Domenico E ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Epileptiform activity; GABA release; Global ischemia; mGlu1 receptors; Neuroprotection; Oxygen glucose deprivation

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 (3' CARBOXYBICYCLO[1.1.1]PENTYL)GLYCINE; 3 METHYL AMINOTHIOPHENE DICARBOXYLIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOPYRIDINE; BACLOFEN; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; BICUCULLINE; METABOTROPIC RECEPTOR ANTAGONIST; MUSCIMOL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN SLICE; CONTROLLED STUDY; EPILEPTIC DISCHARGE; HIPPOCAMPUS; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL CORTEX; EPILEPSY; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GERBILLINAE; HIPPOCAMPUS; MICE; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; RATS; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPTIC TRANSMISSION;

EID: 0036669578     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00080-1     Document Type: Article

References (75)

1. Agrawal S.K., Theriault E., Fehlings M.G. Role of group I metabotropic glutamate receptors in traumatic spinal cord white matter injury. Journal of Neurotrauma. 15:1998;929-941.
2. Alger B.E., Pitler T.A., Wagner J.J., Martin L.A., Morishita W., Kirov S.A., Lenz R.A. Retrograde signalling in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. Journal of Physiology. 496:1996;197-209.
3. Allen J.W., Knoblach S.M., Faden A.I. Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro. Cell Death and Differentiation. 7:2000;470-476.
4. Allen J.W., Vicini S., Faden A.I. Exacerbation of neuronal death by activation of group I metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release. Experimental Neurology. 169:2001;449-460.
5. Aniksztejn L., Otani S., Ben-Ari Y. Quisqualate metabotropic receptors modulate NMDA currents and facilitate the induction of long-term potentiation through protein kinase C. European Journal of Neuroscience. 4:1992;500-505.
6. Aramori I., Nakanishi S. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells. Neuron. 8:1992;757-765.
7. Bao W., Williams A.J., Faden A.I., Tortella F.C. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Research. 922:2001;173-179.
8. Battaglia G., Bruno V., Pisani A., Centonze D., Catania M.V., Calabresi P., Nicoletti F. Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. Molecular and Cellular Neuroscience. 17:2001;1071-1083.
9. Baude A., Nusser Z., Roberts J.D.B., Mulvihill E., McIlhinney R.A.J., Somogyi P. The metabotropic glutamate receptor (mGluR1α) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron. 11:1993;771-787.
10. Berthele A., Laurie D.J., Platzer S., Zieglgansberger W., Tolle T.R., Sommer B. Differential expression of rat and human type I metabotropic glutamate receptor splice variant messenger RNAs. Neuroscience. 85:1998;733-749.
11. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Lodi Rizzini B., Pozzan T., Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature. 391:1998;281-285.
12. Bordi F., Ugolini A. Group I metabotropic glutamate receptors: implications for brain diseases. Progress in Neurobiology. 59:1999;55-79.
13. Bruno V., Battaglia G., Copani A., D'Onofrio M., Di Iorio P., De Blasi A., Melchiorri D., Flor P.J., Nicoletti F. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. Journal of Cerebral Blood Flow and Metabolism. 21:2001;1013-1033.
14. Bruno V., Battaglia G., Kingston A.E., O'Neill M.J., Catania M. V., Di Grezla R., Nicoletti F. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4-carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors. Neuropharmacology. 38:1999;199-207.
15. Bruno V., Ksiazek I., Battaglia G., Lukic S., Leonhardt T., Sauer D., Gasparini F., Kuhn R., Nicoletti F., Flor P.J. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective. Neuropharmacology. 39:2000;2223-2230.
16. Burton, N.R., Smith, D.A.S., Stone, T.W., 1988. A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro. British Journal of Pharmacology 693-701.
17. Bushell T.J., Lee C.C., Shigemoto R., Miller R.J. Modulation of synaptic transmission and differential localisation of mGlus in cultured hippocampal autapses. Neuropharmacology. 38:1999;1553-1567.
18. Carlà V., Moroni F. General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neuroscience Letters. 146:1992;21-24.
19. Chapman A.G., Yip P.K., Yap J.S., Quinn L.P., Tang E., Harris J.R., Meldrum B.S. Anticonvulsant actions of LY 367385 ((+)-2-methyl-4- carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid). European Journal of Pharmacology. 368:1999;17-24.
20. Cozzi A., Attucci S., Peruginelli F., Marinozzi M., Luneia R., Pellicciari R., Moroni F. Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S1′S, 2′S, 3'R)-2-(2′-carboxy-3′-phenylcyclopropyl)glycine, a new potent and selective antagonist. European Journal of Neuroscience. 9:1997;1350-1355.
21. De Vry J., Horvath E., Schreiber R. Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620. European Journal of Pharmacology. 428:2001;203-214.
22. Ferraguti F., Conquet F., Corti C., Grandes P., Kuhn R., Knoepfel T. Immunohistochemical localization of the mGluR1β metabotropic glutamate receptor in the adult rodent forebrain: evidence for a different distribution of mGluR1 splice variants. Journal of Comparative Neurology. 400:1998;391-407.
23. Fiorillo C.D., Williams J.T. Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature. 394:1998;78-82.
24. Fitzjohn S.M., Irving A.J., Palmer M.J., Harvey J., Lodge D., Collingridge G.L. Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices. Neuroscience Letters. 203:1996;211-213.
25. Gereau IV R.W., Conn P.J. Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1. Journal of Neuroscience. 15:1995;6879-6889.
26. Greenwood R.S., Fan Z., McHugh R., Meeker R. Inhibition of hippocampal kindling by metabotropic glutamate receptor antisense oligonucleotides. Molecular and Cellular Neuroscience. 16:2001;233-243.
27. Harrison N.L., Simmonds M.A. Quantitative studies of some antagonists of NMDA in slices of rat cerebral cortex. British Journal of Pharmacology. 84:1985;381-391.
28. Hubert G.W., Paquet M., Smith Y. Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey substantia nigra. Journal of Neuroscience. 21:2001;1838-1847.
29. Johansen F.F., Diemer N.H. Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells. Acta Neurologica Scandinavica. 84:1991;1-6.
30. Jouvenceau A., Dutar P., Billard J.M. Presynaptic depression of inhibitory postsynaptic potentials by metabotropic glutamate receptors in rat hippocampal CA1 pyramidal cells. European Journal of Pharmacology. 281:1995;131-139.
31. Lombardi G., Moroni F. GM1 ganglioside reduces ischemia-induced excitatory amino acid output: a microdialysis study in the gerbil hippocampus. Neuroscience Letters. 134:1992;171-174.
32. Luján R., Nusser Z., Roberts J.D.B., Shigemoto R., Somogyi P. Perisynaptic localization of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. European Journal of Neuroscience. 8:1996;1488-1500.
33. Lyeth B.G., Gong Q.Z., Shields S., Muizelaar J.P., Berman R.F. Group I metabotropic glutamate receptor antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in rats. Experimental Neurology. 169:2001;191-199.
34. Manahan-Vaughan D., Herrero I., Reymann K.G., Sánchez-Prieto J. Presynaptic group 1 metabotropic glutamate receptors may contribute to the expression of long-term potentiation in the hippocampal CA1 region. Neuroscience. 94:1999;71-82.
35. 1 receptor antagonist activity. Neuropharmacology. 38:1999;917-926.
36. Mannaioni G., Carlà V., Moroni F. Pharmacological characterization of metabotropic glutamate receptors potentiating NMDA responses in mouse cortical wedge preparations. British Journal of Pharmacology. 118:1996;1530-1536.
37. Mannaioni G., Marino M.J., Valenti O., Traynelis S.F., Conn P.J. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. Journal of Neuroscience. 21:2001;5925-5934.
38. Marino M.J., Wittmann M., Bradley S.R., Hubert G.W., Smith Y., Conn P.J. Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata. Journal of Neuroscience. 15:2001;7001-7012.
39. Meldrum B.S., Akbar M.T., Chapman A.G. Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Research. 36:1999;189-204.
40. Meli E., Picca R., Attucci S., Cozzi A., Peruginelli F., Moroni F., Pellegrini-Giampietro D.E. Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to post-ischemic neuronal injury in vitro and in vivo. Pharmacology Biochemistry and Behavior. 73:2002;439-446.
41. Merlin L.R. Group I mGluR-mediated silent induction of long-lasting epileptiform discharges. Journal of Neurophysiology. 82:1999;1078-1081.
42. Merlin L.R. Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. Journal of Neurophysiology. 87:2002;621-625.
43. Morishita W., Kirov S.A., Alger B.E. Evidence for metabotropic glutamate receptor activation in the induction of depolarization-induced suppression of inhibition in hippocampal CA1. Journal of Neuroscience. 18:1998;4870-4882.
44. Moroni F., Attucci S., Cozzi A., Meli E., Picca R., Scheideler M.A., Pellicciari R., Noe C., Sarichelou I., Pellegrini-Giampietro D.E. The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death. Neuropharmacology. 42:2002;741-751.
45. 1 type receptors potentiate transmitter output in the rat cortex. European Journal of Pharmacology. 347:1998;189-195.
46. Moroni F., Lombardi G., Thomsen C., Leonardi P., Attucci S., Peruginelli F., Albani Torregrossa S., Pellegrini-Giampietro D.E., Luneia R., Pellicciari R. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. Journal of Pharmacology and Experimental Therapeutics. 281:1997;721-729.
47. Movsesyan V.A., O'Leary D.M., Fan L., Bao W., Mullins P.G.M., Knoblach S.M., Faden A.I. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(phenylethynyl)-pyridine reduce traumatic neuronal injury in vivo and in vitro by antagonizing N-methyl-D-aspartate receptors. Journal of Pharmacology and Experimental Therapeutics. 296:2001;41-47.
48. Mukhin A., Fan L., Faden A.I. Activation of metabotropic glutamate receptor mGluR1 contributes to post-traumatic neuronal injury. Journal of Neuroscience. 16:1996;6012-6020.
49. Nakata N., Kato H., Kogure K. Effects of repeated cerebral ischemia on extracellular amino acid concentrations measured with intracerebral microdialysis in the gerbil hippocampus. Stroke. 24:1993;458-463.
50. Nicoletti F., Bruno V., Catania M.V., Battaglia G., Copani A., Barbagallo G., Ceña V., Sánchez-Prieto J., Spano P.F., Pizzi M. Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. Neuropharmacology. 38:1999;1477-1484.
51. Nusser Z., Mulvihill E., Streit P., Somogyi P. Subsynaptic segregation of metabotropic and ionotropic glutamate receptors as revealed by immunogold localization. Neuroscience. 61:1994;421-427.
52. O'Leary D.M., Movsesyan V.A., Vicini S., Faden A.I. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism. British Journal of Pharmacology. 131:2000;1429-1437.
53. Olpe H.R., Baudry M., Fagni L., Lynch G. The blocking action of baclofen on excitatory transmission in the rat hippocampal slice. Journal of Neuroscience. 2:1982;698-703.
54. Pellegrini-Giampietro D.E., Cherici G., Alesiani M., Carlà V., Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. Journal of Neuroscience. 10:1990;1035-1041.
55. Pellegrini-Giampietro D.E., Cozzi A., Moroni F. The glycine antagonist and free radical scavenger 7-Cl-thio-kynurenate reduces CA1 ischemic damage in the gerbil. Neuroscience. 63:1994;701-709.
56. Pellegrini-Giampietro D.E., Cozzi A., Peruginelli F., Leonardi P., Meli E., Pellicciari R., Moroni F. 1-Amino-1,5-dicarboxylic acid and (S)-(+)-2-(3′-carboxybicyclo[1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia. European Journal of Neuroscience. 11:1999;3637-3647.
57. Pellegrini-Giampietro D.E., Peruginelli F., Meli E., Cozzi A., Albani Torregrossa S., Pellicciari R., Moroni F. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms. Neuropharmacology. 38:1999;1607-1619.
58. Pellicciari R., Luneia R., Costantino G., Marinozzi M., Natalini B., Jakobsen P., Kanstrup A., Lombardi G., Moroni F., Thomsen C. 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors. Journal of Medicinal Chemistry. 38:1995;3717-3719.
59. Pellicciari R., Raimondo M., Marinozzi M., Natalini B., Costantino G., Thomsen C. (S)-(+)-2-(3′, -Carboxybicyclo[1]pentyl)-glycine, a structurally new group I metabotropic glutamate receptor antagonist. Journal of Medicinal Chemistry. 39:1996;2874-2876.
60. Pende M., Lanza M., Bonanno G., Raiteri M. Release of endogenous glutamic and aspartic acids from cerebrocortex synaptosomes and its modulation through activation of a gamma- aminobutyric acid B (GABAB) receptor subtype. Brain Research. 604:1993;325-330.
61. Potashner S.J. Baclofen: effects on amino acid release and metabolism in slices of guinea pig cerebral cortex. Journal of Neurochemistry. 32:1979;103-109.
62. Rao A.M., Hatcher J.F., Dempsey R.J. Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil. Neuroscience Letters. 293:2000;1-4.
63. 2+ channel (VSCC) antagonists ω-Aga-IVA and ω-CTX-MVIIC inhibit spontaneous epileptiform discharges in the rat cortical wedge. Brain Research. 643:1994;352-356.
64. Rodriguez-Moreno A., Sistiaga A., Lerma J., Sánchez-Prieto J. Switch from facilitation to inhibition of excitatory synaptic transmission by group I mGluR desensitization. Neuron. 21:1998;1477-1486.
65. Sanna P.P., Berton F., Cammalleri M., Tallent M.K., Siggins G.R., Bloom F.E., Francesconi W. A role for Src kinase in spontaneous epileptiform activity in the CA3 region of the hippocampus. Proceedings of the National Academy of Science, USA. 97:2000;8653-8657.
66. Schwartz-Bloom R.D., Miller K.A., Evenson D.A., Crain B.J., Nadler J. V. Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study. Neuroscience. 98:2000;471-484.
67. Schwartz R.D., Yu X., Katzman M.R., Hayden-Hixson D.M., Perry J.M. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. Journal of Neuroscience. 15:1995;529-539.
68. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. Journal of Neuroscience. 17:1997;7503-7522.
69. Siniscalchi A., Calabresi P., Mercuri N.B., Bernardi G. Epileptiform discharge induced by 4-aminopyridine in magnesium-free medium in neocortical neurons: physiological and pharmacological characterization. Neuroscience. 81:1997;189-197.
70. 5 receptors and CNS disorders. Trends in Pharmacological Sciences. 22:2001;331-337.
71. Sternau L.L., Lust W.D., Ricci A.J., Ratcheson R. Role for γ-aminobutyric acid in selective vulnerability in gerbils. Stroke. 20:1989;281-287.
72. Strasser U., Lobner D., Behrens M.M., Canzoniero L.M.T., Choi D.W. Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures. European Journal of Neuroscience. 10:1998;2848-2855.
73. Tizzano J.P., Griffey K. I., Schoepp D.D. Induction or protection of limbic seizures in mice by mGluR subtype selective agonists. Neuropharmacology. 34:1995;1063-1067.
74. Varma N., Carlson G.C., Ledent C., Alger B.E. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. Journal of Neuroscience. 21:2001;RC188.
75. Wong R.K., Bianchi R., Taylor G.W., Merlin L.R. Role of metabotropic glutamate receptors in epilepsy. Advances in Neurology. 79:1999;685-698.